MUC1 and interstitial lung disease: In categories 1 and 2, patients with TR-ILD (n = 99) had a significantly higher median serum KL-6 level than those without TR-ILD (n = 30) (531.0 vs. 261.8; p = 0.045) (Fig. 3a).